Vitamin D receptor is required to control gastrointestinal immunity in IL‐10 knockout mice
Open Access
- 13 February 2006
- journal article
- Published by Wiley in Immunology
- Vol. 117 (3) , 310-318
- https://doi.org/10.1111/j.1365-2567.2005.02290.x
Abstract
The vitamin D receptor (VDR) is a nuclear receptor expressed in a number of different cells of the immune system. This study was performed to determine the effect of VDR deficiency on immune function and inflammation of the gastrointestinal tract in a model of inflammatory bowel disease, namely interleukin-10 (IL-10) knockout mice. IL-10 knockout mice were generated which either could or could not respond to vitamin D (double IL-10/VDR knockout; DKO). The distribution and function of lymphocytes in both the primary and secondary lymphoid organs were compared and determined as a function of the severity of intestinal inflammation. DKO mice had normal thymic development and peripheral T-cell numbers at 3 weeks of age, but a week after intestinal disease was detected the thymus was dysplastic with a reduction in cellularity. The atrophy was coupled with increased apoptosis. The spleen weight of DKO mice increased as a result of the accumulation of red blood cells; however, there was a 50% reduction in the numbers of T and B cells. Conversely, the mesenteric lymph nodes were enlarged and contained increased numbers of lymphocytes. The T cells from DKO mice were of a memory phenotype and were hyporesponsive to T-cell receptor stimulation. Colitis in the DKO mice was associated with local and high expression of IL-2, interferon-gamma, IL-1beta, tumour necrosis factor-alpha and IL-12. The primary and secondary lymphoid organs in DKO mice are profoundly altered as a consequence of the fulminating inflammation in the gastrointestinal tract. VDR expression is required for the T cells and other immune cells to control inflammation in the IL-10 KO mice.Keywords
This publication has 31 references indexed in Scilit:
- Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel diseaseEuropean Journal of Immunology, 2004
- Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligandsThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- T-cell development and the CD4–CD8 lineage decisionNature Reviews Immunology, 2002
- The immunoregulatory cytokine interleukin-10-a therapy for Crohn’s disease?Alimentary Pharmacology & Therapeutics, 2001
- Calcium Signaling Mechanisms in T LymphocytesAnnual Review of Immunology, 2001
- Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibilityGut, 2000
- Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?Proceedings of the Society for Experimental Biology and Medicine, 2000
- Immunomodulation of Crohn s DiseasePublished by S. Karger AG ,2000
- Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).Journal of Clinical Investigation, 1984